ACAD
41.57
-0.12
-0.29%
AEMD
6.75
-0.15
-2.17%
APRI
1.87
+0.02
+1.08%
ARNA
4.52
+0.08
+1.80%
ATEC
1.36
-0.03
-2.16%
CNAT
5.02
-0.14
-2.71%
CRXM
0.32
-0.01
-2.02%
CYTX
0.53
-0.018
-3.2505%
DXCM
79.71
+0.35
+0.44%
GNMK
8.97
+0.06
+0.67%
HALO
22.78
+0.68
+3.08%
ILMN
220.51
+0.44
+0.20%
INNV
0.12
0.00
0.00%
INO
7.87
-0.05
-0.63%
ISCO
0.048
+0.005
+10.4651%
ISIS
55.43
-0.7
-1.25%
LGND
98.93
+0.33
+0.33%
LPTN
0.256
-0.019
-6.9793%
MBVX
2.59
-0.12
-4.43%
MEIP
1.74
-0.03
-1.69%
MNOV
3.94
-0.08
-1.99%
MRTX
31.85
+0.55
+1.76%
MSTX
0.462
-0.018
-3.7708%
NBIX
48.32
+1.01
+2.13%
NUVA
47.49
+0.2
+0.42%
ONCS
6.12
-0.23
-3.62%
ONVO
3.73
-0.01
-0.27%
OREX
4.77
+0.01
+0.21%
OTIC
22.06
-0.03
-0.14%
QDEL
22.8
-0.21
-0.91%
RCPT
198.25
+3.34
+1.71%
RGLS
10.32
+0.12
+1.18%
RMD
55.38
+0.07
+0.13%
SCIE
0.015
-0.002
-9.3750%
SPHS
0.8
-0.02
-2.79%
SRNE
17.29
+0.61
+3.66%
TROV
10.1
+0.57
+5.98%
VICL
0.7
0.00
+0.01%
ZGNX
13.03
+0.23
+1.80%
ACAD
41.57
-0.12
-0.29%
AEMD
6.75
-0.15
-2.17%
APRI
1.87
+0.02
+1.08%
ARNA
4.52
+0.08
+1.80%
ATEC
1.36
-0.03
-2.16%
CNAT
5.02
-0.14
-2.71%
CRXM
0.32
-0.01
-2.02%
CYTX
0.53
-0.018
-3.2505%
DXCM
79.71
+0.35
+0.44%
GNMK
8.97
+0.06
+0.67%
HALO
22.78
+0.68
+3.08%
ILMN
220.51
+0.44
+0.20%
INNV
0.12
0.00
0.00%
INO
7.87
-0.05
-0.63%
ISCO
0.048
+0.005
+10.4651%
ISIS
55.43
-0.7
-1.25%
LGND
98.93
+0.33
+0.33%
LPTN
0.256
-0.019
-6.9793%
MBVX
2.59
-0.12
-4.43%
MEIP
1.74
-0.03
-1.69%
MNOV
3.94
-0.08
-1.99%
MRTX
31.85
+0.55
+1.76%
MSTX
0.462
-0.018
-3.7708%
NBIX
48.32
+1.01
+2.13%
NUVA
47.49
+0.2
+0.42%
ONCS
6.12
-0.23
-3.62%
ONVO
3.73
-0.01
-0.27%
OREX
4.77
+0.01
+0.21%
OTIC
22.06
-0.03
-0.14%
QDEL
22.8
-0.21
-0.91%
RCPT
198.25
+3.34
+1.71%
RGLS
10.32
+0.12
+1.18%
RMD
55.38
+0.07
+0.13%
SCIE
0.015
-0.002
-9.3750%
SPHS
0.8
-0.02
-2.79%
SRNE
17.29
+0.61
+3.66%
TROV
10.1
+0.57
+5.98%
VICL
0.7
0.00
+0.01%
ZGNX
13.03
+0.23
+1.80%
Home » Hugo Villar, Ph.D., MBA-Bio

Hugo Villar, Ph.D., MBA-Bio

Hugo O. Villar Ph.D., MBA is director for Science and Technology programs at UC San Diego Extension. He is also President of Altoris, Inc. a San Diego based specializing in information management for the biotech and pharmaceutical industries and providing consulting on discovery technologies. He was Vice President for Chemoproteomics at Triad Therapeutics and Vice President of Discovery Technologies at Telik, Inc. His work resulted in over 80 publications and 18 patents on the development of technologies for drug discovery. He has a Ph.D. in Chemistry and an MBA with a concentration in Pharmaceuticals and Helathcare.